vs
AdvanSix Inc.(ASIX)与VIRTUS INVESTMENT PARTNERS, INC.(VRTS)财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是VIRTUS INVESTMENT PARTNERS, INC.的1.8倍($359.9M vs $199.5M),VIRTUS INVESTMENT PARTNERS, INC.净利率更高(3.6% vs -0.8%,领先4.3%),AdvanSix Inc.同比增速更快(9.4% vs -4.1%),过去两年AdvanSix Inc.的营收复合增速更高(3.4% vs -5.7%)
AdvanSix Inc.是一家美国化工企业,主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部,于2016年分拆独立,2019年预估营收达14亿美元,其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Virtus Investment Partners是一家美国多管理人资产管理企业,旗下汇集多家具备独立投资流程与自有品牌的关联投资管理人,同时也提供非关联子投资顾问服务,为客户提供多元化的资产管理解决方案。
ASIX vs VRTS — 直观对比
营收规模更大
ASIX
是对方的1.8倍
$199.5M
营收增速更快
ASIX
高出13.5%
-4.1%
净利率更高
VRTS
高出4.3%
-0.8%
两年增速更快
ASIX
近两年复合增速
-5.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $359.9M | $199.5M |
| 净利润 | $-2.8M | $7.1M |
| 毛利率 | 7.6% | — |
| 营业利润率 | -0.7% | 7.7% |
| 净利率 | -0.8% | 3.6% |
| 营收同比 | 9.4% | -4.1% |
| 净利润同比 | -892.9% | -78.1% |
| 每股收益(稀释后) | $-0.11 | $1.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASIX
VRTS
| Q1 26 | — | $199.5M | ||
| Q4 25 | $359.9M | $208.0M | ||
| Q3 25 | $374.5M | $216.4M | ||
| Q2 25 | $410.0M | $210.5M | ||
| Q1 25 | $377.8M | $217.9M | ||
| Q4 24 | $329.1M | $233.5M | ||
| Q3 24 | $398.2M | $227.0M | ||
| Q2 24 | $453.5M | $224.4M |
净利润
ASIX
VRTS
| Q1 26 | — | $7.1M | ||
| Q4 25 | $-2.8M | $33.9M | ||
| Q3 25 | $-2.6M | $31.3M | ||
| Q2 25 | $31.4M | $42.7M | ||
| Q1 25 | $23.3M | $28.1M | ||
| Q4 24 | $352.0K | $39.5M | ||
| Q3 24 | $22.3M | $49.1M | ||
| Q2 24 | $38.9M | $26.0M |
毛利率
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
营业利润率
ASIX
VRTS
| Q1 26 | — | 7.7% | ||
| Q4 25 | -0.7% | 19.1% | ||
| Q3 25 | -0.9% | 21.7% | ||
| Q2 25 | 7.7% | 21.5% | ||
| Q1 25 | 7.7% | 16.8% | ||
| Q4 24 | -3.9% | 21.7% | ||
| Q3 24 | 7.5% | 24.3% | ||
| Q2 24 | 11.5% | 19.7% |
净利率
ASIX
VRTS
| Q1 26 | — | 3.6% | ||
| Q4 25 | -0.8% | 16.3% | ||
| Q3 25 | -0.7% | 14.5% | ||
| Q2 25 | 7.7% | 20.3% | ||
| Q1 25 | 6.2% | 12.9% | ||
| Q4 24 | 0.1% | 16.9% | ||
| Q3 24 | 5.6% | 21.6% | ||
| Q2 24 | 8.6% | 11.6% |
每股收益(稀释后)
ASIX
VRTS
| Q1 26 | — | $1.05 | ||
| Q4 25 | $-0.11 | $5.15 | ||
| Q3 25 | $-0.10 | $4.65 | ||
| Q2 25 | $1.15 | $6.12 | ||
| Q1 25 | $0.86 | $4.05 | ||
| Q4 24 | $0.02 | $4.65 | ||
| Q3 24 | $0.82 | $5.71 | ||
| Q2 24 | $1.43 | $2.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $136.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $815.2M | $93.6B |
| 总资产 | $1.7B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASIX
VRTS
| Q1 26 | — | $136.6M | ||
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — |
总债务
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
股东权益
ASIX
VRTS
| Q1 26 | — | $93.6B | ||
| Q4 25 | $815.2M | $934.0M | ||
| Q3 25 | $818.2M | $918.7M | ||
| Q2 25 | $823.7M | $896.4M | ||
| Q1 25 | $794.4M | $893.7M | ||
| Q4 24 | $774.6M | $897.5M | ||
| Q3 24 | $766.4M | $889.0M | ||
| Q2 24 | $746.6M | $868.7M |
总资产
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $4.3B | ||
| Q3 25 | $1.7B | $3.9B | ||
| Q2 25 | $1.6B | $3.7B | ||
| Q1 25 | $1.6B | $3.7B | ||
| Q4 24 | $1.6B | $4.0B | ||
| Q3 24 | $1.5B | $3.6B | ||
| Q2 24 | $1.5B | $3.6B |
负债/权益比
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $63.7M | — |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势,按日历期对齐
经营现金流
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $-67.2M | ||
| Q3 25 | $26.6M | $108.3M | ||
| Q2 25 | $21.1M | $75.8M | ||
| Q1 25 | $11.4M | $-3.8M | ||
| Q4 24 | $64.2M | $1.8M | ||
| Q3 24 | $57.3M | $69.1M | ||
| Q2 24 | $50.2M | $70.0M |
自由现金流
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $-74.1M | ||
| Q3 25 | $66.0K | $106.9M | ||
| Q2 25 | $-7.2M | $74.2M | ||
| Q1 25 | $-22.6M | $-6.8M | ||
| Q4 24 | $29.8M | $-3.8M | ||
| Q3 24 | $26.8M | $68.7M | ||
| Q2 24 | $16.7M | $68.6M |
自由现金流率
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | -35.6% | ||
| Q3 25 | 0.0% | 49.4% | ||
| Q2 25 | -1.7% | 35.2% | ||
| Q1 25 | -6.0% | -3.1% | ||
| Q4 24 | 9.1% | -1.6% | ||
| Q3 24 | 6.7% | 30.3% | ||
| Q2 24 | 3.7% | 30.6% |
资本支出强度
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 3.3% | ||
| Q3 25 | 7.1% | 0.7% | ||
| Q2 25 | 6.9% | 0.7% | ||
| Q1 25 | 9.0% | 1.4% | ||
| Q4 24 | 10.4% | 2.4% | ||
| Q3 24 | 7.7% | 0.2% | ||
| Q2 24 | 7.4% | 0.6% |
现金转化率
ASIX
VRTS
| Q1 26 | — | — | ||
| Q4 25 | — | -1.99× | ||
| Q3 25 | — | 3.45× | ||
| Q2 25 | 0.67× | 1.77× | ||
| Q1 25 | 0.49× | -0.13× | ||
| Q4 24 | 182.29× | 0.04× | ||
| Q3 24 | 2.57× | 1.41× | ||
| Q2 24 | 1.29× | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |